Texas Top Legal Officer Takes Legal Action Against Acetaminophen Makers Regarding Autism Spectrum Assertions

The top legal official in Texas Paxton is filing a lawsuit against the producers of Tylenol, asserting the firms concealed alleged dangers that the medication presented to pediatric cognitive development.

The court filing arrives a month after Former President Trump publicized an unproven link between consuming Tylenol - alternatively called paracetamol - while pregnant and autism in children.

Paxton is suing the pharmaceutical giant, which once produced the drug, the only pain reliever approved for pregnant women, and Kenvue, which now manufacturers it.

In a official comment, he stated they "misled consumers by profiting off of suffering and marketing drugs ignoring the potential hazards."

The company states there is lacking scientific proof connecting acetaminophen to autism.

"These corporations deceived for years, deliberately risking millions to boost earnings," the attorney general, from the Republican party, declared.

Kenvue stated officially that it was "very worried by the dissemination of inaccurate information on the safety of paracetamol and the potential impact that could have on the health of American women and children."

On its online platform, Kenvue also said it had "continuously evaluated the relevant science and there is insufficient valid information that shows a verified association between using acetaminophen and autism."

Organizations acting on behalf of doctors and healthcare providers concur.

ACOG has stated acetaminophen - the main ingredient in acetaminophen - is a restricted selection for women during pregnancy to manage discomfort and elevated temperature, which can pose significant medical dangers if left untreated.

"In over twenty years of studies on the consumption of paracetamol in gestation, not a single reputable study has successfully concluded that the usage of paracetamol in any stage of pregnancy results in brain development issues in offspring," the association stated.

This legal action mentions current declarations from the Trump administration in claiming the medication is allegedly unsafe.

Recently, Trump generated worry from public health officials when he told women during pregnancy to "struggle intensely" not to use Tylenol when unwell.

The FDA then published an announcement that doctors should contemplate reducing the use of Tylenol, while also stating that "a direct connection" between the medication and autism in young ones has not been established.

Health Secretary Kennedy, who supervises the FDA, had vowed in spring to undertake "comprehensive study program" that would identify the cause of autism in a short period.

But specialists warned that finding a single cause of autism spectrum disorder - considered by experts to be the consequence of a complex mix of inherited and surrounding conditions - would prove challenging.

Autism is a form of permanent neurological difference and impairment that impacts how persons encounter and interact with the world, and is recognized using physician assessments.

In his lawsuit, Paxton - aligned with the former president who is campaigning for the Senate - asserts the manufacturer and J&J "willfully ignored and sought to suppress the research" around acetaminophen and autism.

The case attempts to require the corporations "destroy any marketing or advertising" that asserts acetaminophen is reliable for pregnant women.

The court case parallels the grievances of a assembly of parents of children with autism and attention deficit hyperactivity disorder who sued the manufacturers of Tylenol in two years ago.

The court threw out the lawsuit, stating investigations from the plaintiffs' authorities was not conclusive.